2003, BioTech and Medicare - Connected Health Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2003

BioTech

Medicare

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

JANUARY 18, 2019

back in 2003 — so we’ve known for over 16 years that in the U.S., From 2003 to 2019, the theory that prices are the primary driver of America’s spending more on health care than any other country is still the case. Two news items illustrate this issue in real time.

BioTech

BioTech Medicare Medical Billing Patient Experience

Will Foot Ulcer Treatment Survive Medicare Rollback?

Insulin Nation

DECEMBER 18, 2013

A state-of-the-art wound therapy that prevents amputations is under threat from proposed cuts in Medicare reimbursement rates, according to regenerative medicine experts. A 2003 study on Dermagraft undertaken throughout 35 U.S. Apligraf, pictured here, is a dressing made of living cells used to help heal diabetic foot ulcers.

Medicare

Medicare BioTech Pharmaceuticals

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Will Foot Ulcer Treatment Survive Medicare Rollback?

Stay Connected